• 제목/요약/키워드: Renal diseases

검색결과 895건 처리시간 0.02초

익수 후 발생한 흡인성 폐렴에서 유발된 파종성 Scedosporium apiospermum 감염 1예 (Disseminated Scedosporium apiospermum Infection Induced from Aspiration Pneumonia after Near-Drowning)

  • 원호연;김형래;김동환;오재원;기정혜;한창훈;이선민;김정주
    • Tuberculosis and Respiratory Diseases
    • /
    • 제69권4호
    • /
    • pp.298-302
    • /
    • 2010
  • Scedosporium apiospermum, the anamorph of Pseudallescheria boydii, is a ubiquitous saprophytic fungus. S. apiospermum can cause life-threatening infections usually in immunocompromised patients or after near-drowning incidents. Here, we report the first case of disseminated infection caused by S. apiospermum after near-drowning in Korea. A 44-year-old healthy man developed aspiration pneumonia, followed by multiple brain abscesses, and endopthalmitis, after a near-drowning incident in a septic tank. S. apiospermum infection was diagnosed on the 33rd day after the incident had occurred. The patient died from the progressive renal failure 255 days after incident, although he had been treated with voriconazole.

소아개심술 후 시행한 순환보조장치의 임상적 고찰 (Postcardiotomy Mechanical Circulatory Support in Congenital Heart Diseases)

  • 권오춘;이영탁
    • Journal of Chest Surgery
    • /
    • 제33권5호
    • /
    • pp.385-390
    • /
    • 2000
  • Background: To review the experience that used both ventricular assist device(VAD) and extracorporeal membrane oxygenation(ECMO) for children with congential heart disease requiring postcardiotomy mechanical circulatory support. Material and Method: Between March 1993 and May 1995, we applied mechanical assist device using centrifugal pump to the 16 patients who failed to be weaned from cardiopulmonary bypass(n=15) or had been in cardiogenic shock in intensive care unit(n=1). The diagnosis were all congenital heart diseases and the ages of patients ranged from 20 days to 10 years (mean age=2.5$\pm$3.5 years). Result: The methods of mechanical circulatory support were LVAD(n=13), BVAD (n=1), and ECMO(n=2). The mean assist times were 54.0$\pm$23.7 hours. Post-assist complications were in orders: bleeding, acute renal failure, ventricular failure, respiratory failure, infection, and neurologic complication. It was possible for 9 patients(56.3%) to be weaned from assist device and 5 patients(31.3%) were discharged from hospital. There was no statistical significant between hospital discharged group and undischarged group by age, body weight, cardiopulmonary bypass time, and assist time. Conclusion: The ventricular assist device is an effective modality in salvaging the patient who failed to be weaned from cardiopulmonary bypass, but multiple factors must be considered for improving the results of mechanical circulatory support ; such as patient selection, optimal time of starting the assist device, and prevention and management of the complications.

  • PDF

전신성 흥반성 낭창에 동반된 대동맥 판막 협착증의 수술 1에 (Aortic Stenosis in Systemic Lupus Erythematosus Syndrome)

  • 최주원;김우식;고행일;강윤경;김용인
    • Journal of Chest Surgery
    • /
    • 제37권7호
    • /
    • pp.613-616
    • /
    • 2004
  • 전신성 홍반성 낭창은 자가면역질환의 일종으로 피부, 신장 및 심장에 빈번히 침범하는 질환으로 알려져 있으며, 심장에서는 심외막염, 심근염 및 심장 판막 질환을 발생시킬 수 있다. 전신성 홍반성 낭창에서의 심장 판막 질환은 주로 승모판막 및 대동맥 판막 폐쇄부전증인 것으로 알려져 있으며, 대동맥 판막의 협착증이 보고는 극히 적었다. 또한, 판막성 심장 질환이 발생하여도 다른 장기의 손상으로 인하여 수술을 받는 경우는 매우 드물며 국내보고도 확인되지 않았다. 저자들은 전신성 홍반성 낭창으로 받아오던 59세 여자 환자에게서 대동백 판막 협착증이 발생하였으며 이를 수술 치험하였기에 보고하는 바이다.

항암치료 후 완전관해된 소세포암과 동반된 막성사구체신염 1예 (A Case of Membranous Glomerulonephritis Associated with Small Cell Lung Cancer Being Complete Remmission with Chemotherapy)

  • 백종해;박지영;유성근;박혜정;신경철;정진홍;이관호
    • Tuberculosis and Respiratory Diseases
    • /
    • 제52권6호
    • /
    • pp.633-639
    • /
    • 2002
  • 저자들은 소세포폐암과 막성신증이 동시에 발견된 60세 남자 환자에서 수술 및 전신항암치료 후 폐암의 완전관해와 더불어 단백뇨가 소실되었던 1예를 경험하였기에 문헌고찰과 함께 보고하는 바이다.

간세포암의 기관지내 전이 (Endobronchial Metastases of Hepatocellular Carcinoma)

  • 하근우;강풍;최효진;주미;진성림;진재용;이혁표;최수전;염호기
    • Tuberculosis and Respiratory Diseases
    • /
    • 제51권4호
    • /
    • pp.386-389
    • /
    • 2001
  • An endobronchial metastasis is defined as a subsegmental or a more proximal central bronchial metastasis of a nonpulmonary neoplasm in the bronchoscopically visible range. However, the frequencies of endobronchial metastasis range from 2 to 50% of pulmonary metastases from extrathoracic neoplasms by a different definition of an endobronchial metastasis. Primary neoplasms of an endobronchial metastasis including breast cancer, colon cancer, renal cell carcinoma, and ovarian cancer are relatively common. However, an endobronchial metastasis arising from thyroid cancer, parotid gland tumor, bone tumor, bladder cancer, and stomach cancer has only rarely been reported in the literature. Here we report a case of an endobrochial metastases from a hepatocellular carcinoma.

  • PDF

신혈관근지방종을 동반한 결절성 경화증에서 발생한 폐림프관평활근종증 1예 (A Case of Pulmonary Lymphangioleiomyomatosis Developed in Tuberous Sclerosis with Renal Angiomyolipoma)

  • 김명임;강홍모;이호종;고용호;조용선;유지홍
    • Tuberculosis and Respiratory Diseases
    • /
    • 제48권5호
    • /
    • pp.788-793
    • /
    • 2000
  • 결절성 경화증의 폐침윤은 드문 것으로 알려져 있는데 저자들은 결절성 경화증과 신장의 혈관근지방종으로 추적 관찰중인 환자에서 폐의 기흉이 발생하여 고해상 전산화단층촬영과 병리조직소견에서 HMB-45 양성인 평활근의 증식을 보인 폐의 림프관평활근종증을 진단받은 1예를 경험하였기에 보고하는 바이다.

  • PDF

Vascular endothelial growth factor-dependent and -independent regulation of angiogenesis

  • Shibuya, Masabumi
    • BMB Reports
    • /
    • 제41권4호
    • /
    • pp.278-286
    • /
    • 2008
  • Angiogenesis, the formation of blood vessels, is essential for preparing a closed circulatory system in the body, and for supplying oxygen and nutrition to tissues. Major diseases such as cancer, rheumatoid arthritis, and atherosclerosis include pathological angiogenesis in their malignant processes, suggesting anti-angiogenic therapy to be a new strategy for suppression of diseases. However, until the 1970s, the molecular basis of angiogenesis was largely unknown. In recent decades, extensive studies have revealed a variety of angiogenic factors and their receptors, including vascular endothelial growth factor (VEGF)-VEGFRs, Angiopoietin-Tie, Ephrin-EphRs and Delta-Notch to be the major regulators of angiogenesis in vertebrates. VEGF and its receptors play a central role in physiological as well as pathological angiogenesis, and functional inhibitors of VEGF and VEGFRs such as anti-VEGF neutralizing antibody and small molecules that block the tyrosine kinase activity of VEGFRs have recently been approved for use to treat patients with colorectal, lung, renal and liver cancers. These drugs have opened a novel field of cancer therapy, i.e. anti-angiogenesis therapy. However, as yet they cannot completely cure patients, and cancer cells could become resistant to these drugs. Thus, it is important to understand further the molecular mechanisms underlying not only VEGF-VEGFR signaling but also the VEGF-independent regulation of angiogenesis, and to learn how to improve anti-angiogenesis therapy.

Hop 유래 Xanthohumol 화합물에 의한 Proteasome계의 유도발현 (Induction of the Proteasome Subunits by Xanthohumol Compounds from Hops)

  • 이향림;이용록;곽미경
    • 약학회지
    • /
    • 제54권6호
    • /
    • pp.481-487
    • /
    • 2010
  • The proteasome plays a major role in the degradation of abnormal proteins within the cell. Therefore, repressed proteasome function is accepted as one of factors contributing the pathogenesis of multiple degenerative diseases. In the present study, we have observed that xanthohumol C, which is one of prenylated flavonoids from hops, increases the expression of the proteasome subunits through the Nrf2 pathway. Treatment of murine renal epithelial TCMK-1 cells with xanthohumol C and its methoxymethoxy-derivative elevated the expression of the Antioxidant Response Element (ARE)-driven reporter gene, as well as Nrf2-target genes including NAD(P)H: quinoneoxidoreductaes 1 (Nqo1). Transcript levels for the catalytic subunits of the proteasome Psmb5 and Psmb6 were increased by these compounds. The activation of the psmb5 promoter by xanthohumol C was abolished when the ARE in this promoter was mutated, indicating that proteasome induction was mediated by the Nrf2-ARE pathway. These results suggest that xanthohumol compounds from hops have a potential benefit on various oxidative stress-associated human diseases through the induction of the proteasome.

폐렴구균백신의 효과 (Efficacy of Pneumococcal Vaccines)

  • 박호선
    • Journal of Yeungnam Medical Science
    • /
    • 제29권1호
    • /
    • pp.1-8
    • /
    • 2012
  • Streptococcus pneumonia is a very important pathogen for children and elderly people. Two types of pneumococcal vaccines are available in the market: pneumococcal polysaccharide vaccine (PPSV) and pneumococcal conjugate vaccine (PCV). PPSVs have been used for more than 30 years, and PCVs for about 10 years. There have been many reports concerning the evaluation of the vaccines' efficacies in preventing pneumococcal diseases such as meningitis, pneumonia, and otitis media and bacteremia, but the clinical trials had been performed with different conditions, such as diverse vaccine valencies, age groups, races, target outcomes, immunological cut-off values, and follow-up periods. PPSV is recommended for elderly people and chronic disease patients such as asthma, diabetes mellitus, chronic renal failure, and hyposplenic patients. According to the data from several systemic reviews and population-based surveillances, PPSV is effective for pneumococcal pneumonia and vaccine-type bacteremia among healthy adults. Until now, however, there is insufficient evidence of the effectiveness of PPSV among high-risk adults. PCV is very effective in preventing vaccine-type invasive pneumococcal disease (IPD) among children, but its efficacy for pneumonia is very low among children. The incidence of vaccine-related or non-vaccine-type IPDs is increasing after the introduction of 7-valent PCV (PCV7) as a routine immunization for children. Recently, 10- and 13-valent PCVs have been used for children, instead of PCV7. Therefore, continuous surveillance for serotype change among pneumococcal diseases is necessary to evaluate the vaccines' efficacy.

  • PDF

혈관질환 억제 효능이 있는 BDR-29의 백서 신장 독성연구 (Study on Kidney Toxicity of BDR-29 for Treatment Vascular Diseases in Rats)

  • 김은주;강대길;이안숙;최덕호;조국현;김성연;이호섭
    • 대한한의학방제학회지
    • /
    • 제16권2호
    • /
    • pp.163-169
    • /
    • 2008
  • The kidney toxicities of BDR-29 used for improvement of the vascular diseases, was examined using male and female Sprague-Dawley rats. The male and female rats were divided into 4 groups for intragastrical treatment with doses of 0, 5, 50, and 500 mg/kg/day for 13 weeks, respectively. In all male and female rats treated with BDR-29, no mortality and gross pathological findings were shown for 13 weeks. There substantially was no change in body weight in all rats with treatment of BDR-29. The renal functional parameters including urinary volume, urine osmolality, electrolytes excretory rate, creatinine clearance, and solute-free water reabsorption were not exchanged in all rats treated with BDR-29. Taken together, these results suggest that BDR-29 has no toxicity on kidney in all male and female rats.

  • PDF